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ABSTRACT 
The objective of the present study was to formulate the gastro-retentive floating tablets containing Ibuprofen, which would remain 
in stomach and/or upper part of GIT for prolonged period of time. Floating systems have low bulk density so that they can float on 
the gastric juice in the stomach. Ibuprofen is an anti inflammatory drug.  On trial and error basis formulation design was done. 
Four different batches of floating tablets of Ibuprofen were prepared using HPMC, Xanthan gum, and gas generating agent sodium 
bicarbonate and citric acid. The tablets were characterized for the pre and post compression parameters such as friability, hardness, 
thickness, drug content, weight variation, in-vitro buoyancy studies and 13 hrs in-vitro drug release studies and the results were 
within the limits. From the results obtained, it was concluded that the optimized formulation F4 desired drug release properties and 
floating behavior. 
Keywords: Citric acid, gastro-retentive floating tablets, HPMC K4M, Ibuprofen, sodium bicarbonate, xanthan gum. 
 
 
Article Info: Received 13 June 2018;   Revised 26 August; Accepted 3 September, Available online 15 September 2018 
Cite this article- 
Saddam C Shaikh, Dnyaneshwar Sanap, Dipak V Bhusari, Shirish Jain, Pooja P Kochar, Vikram N Sanchati. 
Formulation and evaluation of Ibuprofen gastro-retentive floating tablets. Universal Journal of Pharmaceutical 
Research. 2018; 3(4): 20-25. 
DOI: https://doi.org/10.22270/ujpr.v3i4.178  
Address for Correspondence: 
Saddam C Shaikh, Rajarshi Shahu College of Pharmacy, Buldana, Maharashtra, India. E-mail: saddamshaikh.bld@gmail.com. 
 
INTRODUCTION 
Administration of drugs by oral route offers ease 
administration and gastrointestinal physiology offers 
more flexibility in dosage form design than other 
routes
1
. Drugs that are easily absorbed from 
gastrointestinal tract (GIT) and have short half lives are 
eliminated quickly from the systemic circulation. So, 
there is need of frequent dosing of these drugs is 
required to achieve desired therapeutic activity. To 
avoid this, the development of oral sustained/controlled 
release formulations is an attempt to release the drug 
slowly into the GIT and maintain an effective drug 
concentration in the systemic circulation for a long 
time. Floating drug delivery systems (FDDS) were first 
described by Davis in 1968
2
.  Floating systems or 
Hydro-dynamically controlled systems are low-density 
systems that have sufficient buoyancy to float over the 
gastric contents and remain buoyant in the stomach 
without affecting the gastric emptying rate for a 
prolonged period of time while the system is floating 
on the gastric content; the drug is released slowly at the 
desired rate from the floating system. After release of 
drug, the residual system is emptied from the stomach
3
. 
This results in an increased Gastric retention time and a 
better control of the fluctuations in plasma drug 
concentration
4
. 
Gastro retentive systems confine the dosage forms for 
several hours inside the stomach and considerably 
prolong the gastric residence time of drugs
5
. Prolonged 
gastric retention improves bioavailability, reduces drug 
waste, and improves solubility for drugs that are less 
soluble in a high pH environment. It is also beneficial 
for local drug delivery to the stomach and proximal 
small intestines
6
. 
Ibuprofen (iso-butyl-propanoic-phenolic acid) is a non-
steroidal anti-inflammatory drug (NSAID). It is a 
propionic acid derivatives
7
. It is used for treatment of 
rheumatoid arthritis, degenerative joint disease, 
osteoarthritis, acute musculoskeletal disorders, and low 
back pain, fever.  
The bioavailability of the drug is 87-100% and the 
protein binding capacity is 98%
8
. It is metabolized by 
liver and it has a plasmatic half-life of 1.8–2.0 h as a 
result, it has to be administered three to six times a day. 
It is excreted through urine
9
. 
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Hydrophilic polymer matrix is widely used for 
formulating sustained release dosage form. 
HPMC is widely used hydrophilic polymer to prolong 
drug release due to its rapid hydration, good 
compression and gelling characteristics along with its 
ease of use, availability, and very low toxicity. It 
regulates the release of drug by controlling the swelling 
and cross-linking
10,11
. 
The main intention of this work was to formulate a 
single unit floating tablets of ibuprofen with use of 
HPMC for the release of the drug after a definite lag 
time and provides required concentration of drug at 
regular intervals of time which results reduction in 
frequency of dose of administration and will improve 
patient compliance
12
. 
 
MATERIALS AND METHODS 
Ibuprofen was obtained as a gift sample from Leben 
Parma, Akola, Maharashtra, India. HPMC K4M, 
Xanthan gum, Citric acid, lactose and Sodium 
bicarbonate, Talc and MCC were obtained from 
Research Lab, Akola, Maharashtra, India. All the 
chemicals and reagents required for the present 
experimental work are of analytical grade. 
Standard Calibration Curve 
10 mg of Ibuprofen was weighed and dissolved in 10 
ml of phosphate buffer 6.8, to give a solution of 1000 
μg/ml concentration. From this solution 1 ml was taken 
and diluted to 10ml using Phosphate buffer 6.8 to 
produce a stock solution of 100 μg/ml. From this stock 
solution different concentrations were prepared. The 
absorbance of these solutions was measured at 221 nm 
by UV spectrophotometer (Jasco V530 plus)
13
.  
Fourier Transform Infra-Red (FTIR) Spectroscopy 
Interaction of drug with excipients was confirmed by 
carrying out IR interactions studies. Drug and 
excipients used in study were placed in air tight screw 
cap amber colored vials, then vials were kept at room 
temperature as well as in hot air oven at 40
0
C for one 
week to get them moisture free and FT-IR analysis was 
carried out with saturated potassium bromide using 
pellet making method. Standard and KBr were taken in 
the ratio of 1:300 to make a solid disc or pellet with the 
help of Hydraulic Pellet Machine
14,15
. 
Powder characterization 
1. Bulk Density: It refers to packing of particles. The 
bulk density of the formulated granules was evaluated 
using a bulk density apparatus
16
. It is expressed in 
gm/ml and is given by 
Bulk density =
Mass of the powder
Volume of the bulk powder
 
 
2. Tapped density 
Weighed quantity of tablet blend was into a graduated 
cylinder. Volume occupied by the drug was noted 
down. Then cylinder was subjected to 100, 200 and300 
taps in tap density apparatus
17
. According to USP, 
Tapped density =
Mass of the powder
Tapped volume of the powder
 
3. Carr’s Index (Compressibility) 
The compressibility index and Hausner ratio was 
measures the property of powder to be compressed. 
The packing ability of tablet blend was evaluated from 
change in volume, which is due to rearrangement of 
packing occurring during tapping
18
.  
It was indicated as Carr’s compressibility index was 
calculated by following formula-  
Carr’s index  % =
Tapped density − Bulk density
Tapped density
 X100 
 
4. Hausner Ratio 
It is measurement of frictional resistance of tablet 
blend
19
. The ideal range should be 1.2-1.5. It was 
determined by the ratio of tapped density and bulk 
density 
Hausner′s ratio =
Tapped density
Bulk density
  
5. Angle of Repose  
It is defined as the maximum angle that can be 
obtained between the free standing of powder heap and 
horizontal plane2
0
.  It was determined by the following 
equation: 
tan θ =
h
r
  
Where, θ = Angle of repose. 
h = of powder heap. 
r = Radius of the powder cone. 
Preparation of Ibuprofen floating tablets 
The composition of different formulations of Ibuprofen 
floating tablets is shown in Table 2.  
All the ingredients were accurately weighed and passed 
through mesh 60#. In order to mix the ingredients 
thoroughly drug and polymer were blended and 
geometrically in a mortar and pestle for 15 minutes 
then magnesium stearate, sodium bicarbonate, talc, 
lactose and magnesium stearate were mixed one by 
one. After thoroughly mixing the ingredients, the 
powder was blend was passed through 44# sieve and 
compressed on rotary tablet punching machine. (Made-
Krishna Engineering)
21,22
. 
Post compression parameters of Ibuprofen floating 
tablets 
1. Weight uniformity test 
Twenty Ibuprofen tablets were weighed individually, 
average weight was calculated and individual tablet 
weights were compared to the, average weight. The 
tablets met the USP test if no more than 2 tablets are 
outside the percentage limit and if no tablet differs by 
more than two times the percentage limit
23
.  
2. Hardness test 
The hardness of the tablets was determined using 
Monsanto Hardness tester. It is expressed in kg/cm
2
. 
Six tablets were randomly picked from each 
formulation and the mean and standard deviation 
values were calculated
24
. 
3. Friability 
A friability test was conducted on Ibuprofen floating 
tablets using a Roche friabilator. Twenty tablets were 
selected from each batch and any loose dust was 
removed with the help of a soft brush. The tablets were 
initially weighed and transferred into friabilator. The 
drum was rotated at 25 rpm for 4 minutes after which 
the tablets were removed. Any loose dust was removed 
from the tablets as before and the tablets were weighed 
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again
25,26
. The percentage friability was then calculated 
by, 
% Friability =
Initial weight − Final weight
Final weight
 X100 
4. Lag Time  
The In vitro buoyancy was determined by the lag time. 
The Ibuprofen tablets were placed in a 100 ml beaker 
containing 0.1 N HCl. The time required for a tablet to 
rise to the surface for floating was determined as the 
lag time
27
. 
5. Floating Time  
The Ibuprofen tablets were placed in a 100 ml glass 
beaker containing 0.1 N HCl. The time for which the 
tablet remained floating on the surface of medium was 
determined as floating time
28
. 
6. Drug Content  
Ten Ibuprofen tablets were weighed and average 
weight was calculated. All the 10 tablets were crushed 
in a mortar. The powder equivalent to 10 mg was 
accurately weighed, dissolved in 5 ml of Methanol and 
made up to 100 ml of 0.1 N HCl. The volumetric flask 
was then shaken for approximately 20 minutes. The 
solution was filtered and 1 ml of filtrate was diluted to 
10 ml using 0.1 N HCl. Absorbance was measured at 
221 nm using 0.1 N HCl as a blank. The amount of 
drug present in one tablet was calculated
29
. 
7. In vitro release studies  
In vitro drug release study for the prepared Ibuprofen 
floating tablets were conducted for period of 13 hours 
using a six station USP XXVI type II (paddle) 
apparatus at 37±0.5
0
C and 50 rpm speed. The 
dissolution studies were carried out in triplicate for 10 
hours in phosphate buffer of pH 6.8 under sink 
condition. At first half an hour and then every 1 hour 
interval samples of 5 ml were withdrawn from 
dissolution medium and replaced with fresh medium to 
maintain the volume constant. After filtration and 
appropriate dilution, the sample solution was analyzed 
at 221 nm for Ibuprofen by a UV- spectrophotometer
29
.  
 
RESULTS AND DISCUSSION 
Floating tablets of Ibuprofen were developed in order 
increase the gastric residence time of drug, so that they 
can be retained in stomach for longer time to reduce 
the frequency of administration.  
Four different batches of tablets were made using 
HPMC K4M, along with effervescing agent sodium 
bicarbonate and citric acid to optimize the drug 
content, in-vitro buoyancy and in-vitro drug dissolution 
studies.  
The selection of viscosity grade of a polymer is an 
important consideration in the formulation of tablet. 
All the formulations were prepared by direct 
compression method. Preformulation is the first step in 
development of new formulation. Characteristic 
absorption bands in FTIR spectrum of the drug sample 
showed and proved identity of drug. There was no 
interaction found in between drug and other 
ingredients. Absorption maxima of the Ibuprofen were 
determined by UV spectrophotometric method using 
UV/Visible spectrophotometer. The λmax of Ibuprofen 
in phosphate buffer 6.8 is 221 nm. The standard curves 
of Ibuprofen were prepared in Phosphate buffer 6.8 in 
the concentration range of 10 to 50µg/ml. A straight 
line with r
2
=0.9992 was found indicating that the drug 
follows Beer’s law within the specified concentration 
range. 
The value of Hausner’s ratio varies from 1.13-1.17.  
Bulk density varies from 0.222-0.251 and tapped 
density varies from 0.260-0.289. Whereas angle of 
repose varied from 22-31° which ensured good flow 
properties of powder. Carr’s Index varies from 11.92 -
15.15. 
The general appearance of tablets, its visual identity 
and overall ‘elegance’ is essential for acceptability, the 
shape of all the formulation remained off white, 
smooth, flat faced circular and no visible cracks.  
In a weight variation test, the Pharmacopoeial limit for 
percentage deviation for the tablets of more than 250 
mg is ± 5%
18
. The average percentage deviation of all 
the tablet formulations was found to be within the 
above limit, and hence all the formulations passed the 
test for uniformity of weight as per the official 
requirements.  
The hardness of the tablet was measured by Monsanto 
tester and was ranged between 3.7±0.93 to 6.3±0.98 
Kg/cm
2
. Increasing tablet hardness provided a much 
great control over dissolution rate. The resistance of 
tablets to shipping or breakage, under conditions of 
storage, transportation and handling before usage 
depends on its hardness
22
. 
Friability is the measure of tablet strength. The 
friability was measured by Roche friabilator and was 
found 0.2 to 0.7 %, and this parameter given the 
satisfactory mechanical resistance of the tablet. In the 
present study the percentage friability for all the 
formulations was below 1% indicating that the 
friability is within the prescribed limits
26
.  
The drug content estimations showed values in the 
range of 97.58±0.47 to 99.57±0.06 %.   These results 
showed the good drug content uniformity of the tablet.  
The release profiles of formulations F1, F2, F3 and F4, 
are shown in Figure 4. The release of drug mainly 
depends upon the polymer concentration. Maximum 
release was shown by formulation of batch F4 
(47.38%), and minimum by the formulations of batch 
F2 (34.46%) in the duration of 13 hrs. The release 
profiles showed tri-phasic with initial burst effect (less 
than 30 min) followed by a polymer-controlled slower 
release in the second phase. The difference in burst 
effect was the result of difference in the viscosity of the 
polymers. It is reported that citric acid level greatly 
influenced the drug release, irrespective of 
hydroxypropyl methyl cellulose grade. 
Lactose was used as diluents as well as channeling 
agent in the floating delivery of the drug. In vitro 
release profile showed that on increasing the 
concentration of lactose release rate increased. Floating 
lag time for formulations of batches was found to in the 
range of 100±1.78 to 240±1.59 sec. 
The concentration of gas generating agent affected the 
floating lag time, as the amount of gas-generating agent 
was increased, the floating lag time decreased. The 
incorporation of gas generating agent exhibited 
reduction in the floating lag time. 
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After the analysis of the above formulation and 
optimization study we can conclude that optimized 
formulation of batch F4 is the best and promising 
formulation for the delivery of the Ibuprofen in order to 
provide the controlled release and increased gastro 
retentive drug delivery system to reduce frequency of 
its administration. 
 
CONCULSION 
The ultimate aim of the present study was to prepare 
gastroretentive floating tablet of Ibuprofen using 
polymers like HPMC K4M by direct compression 
method. FTIR study concludes no drug polymer 
interaction. Different pre compression properties like 
Carr,s Index, Hausner ratio indicate good flow 
properties of powder. The formulations were evaluated 
for various parameters like hardness, friability, weight 
variation, floating lag time, floating time, in-vitro drug 
release etc.  Based on different evaluation parameters 
formulation of batch F4 was concluded as an optimum 
formulation. 
The present research work was successful in improving 
the efficacy of Ibuprofen oral therapy as the drug 
release was extended reducing dosing frequency 
thereby improving patient compliance. 
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Figure 1: Standard calibration curve of Ibuprofen 
 
 
Figure 2: FTIR spectrum of Ibuprofen 
 
 
Figure 3: FTIR spectrum of mixture of Ibuprofen, HPMC K4M 
 
 
Table 1: Results of physical evaluation of pre-compression blend 
Batch 
code 
Angle of 
repose (θ) 
Bulk 
Density 
Tapped 
Density 
Carr’s 
Index 
Hausner’s 
ratio 
F1 21 0.224 0.264 15.15 1.17 
F2 22 0.222 0.260 14.61 1.17 
F3 26 0.251 0.289 13.14 1.15 
F4 25 0.229 0.260 11.92 1.13 
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Table 2: Composition of different Ibuprofen floating tablets 
Batch 
code 
 
Ibuprofen 
(mg) 
 
HPMC 
K4M 
(mg) 
Xanthan gum 
(mg) 
 
NaHCo3 
(mg) 
 
M.C.C 
(mg) 
 
Citric acid 
(mg) 
 
Lactose 
(mg) 
 
Mg stearate 
(mg) 
 
Talc 
(mg) 
 
F1  100  25 12  20  38  15  13  5  5 
F2  100  12 25  18 38  12  11  5  5 
F3  100  37 37  25  38  18  18 5  5 
F4  100  50 50  30  38  25  20  5  5 
 
 
Table 3: Evaluation parameters of Ibuprofen floating tablets 
Batch 
code 
 
 
Average 
weight 
(gm.), 
n=20 
Hardness 
(kg/cm
3
), 
n=6 
 
Friability 
(%), n=20 
 
 
Buoyancy 
lag 
time (sec) 
 
Total 
floatation 
time (hrs) 
 
% Drug 
Content, 
n=10 
F1  
 
0.485±0.03 3.7 ±0.93 
 
0.7 
 
120±1.01 
 
>10 
98.86±0.15 
 
F2  
 
0.492±0.14 
 
6.3 ±0.98 0.3 
100±1.78 
  
>8 
98.32±0.09 
F3  
 
0.500±0.25 
 
4.2 ±1.26 0.5 
200±1.46 
  
>10 
97.58±0.47 
F4  
 
0.468±0.09 
 
5.9 ±1.35 0.2 240±1.59 >11 
99.57±0.63 
 
 
 
 
Figure 4: In-vitro % drug release profiles of Ibuprofen floating tablets 
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